Drug intelligence / Profile preview

Jianpi Jieyu Gao

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Jianpi Jieyu Gao is a Traditional Chinese Medicine (TCM) herbal formulation developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of mild to moderate major depressive disorder, specifically targeting the TCM patterns of heart-spleen deficiency and liver qi stagnation. The medication is prepared as a concentrated herbal paste (Gao Fang), a traditional dosage form used for sustained therapeutic effect. It has been evaluated in prospective, randomized, double-blind, placebo-controlled clinical trials (e.g., ChiCTR2200065205) to assess its impact on depressive and anxiety symptoms using scales such as the 17-item Hamilton Depression Rating Scale (HAMD-17) and the Hamilton Anxiety Rating Scale (HAMA).

Other names: Jianpi Jieyu Gao

Beyond the preview

Go deeper on Jianpi Jieyu Gao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianpi Jieyu Gao.

Explore the full profile